Celsius (NASDAQ:CELH – Free Report) had its target price trimmed by Piper Sandler from $49.00 to $36.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. Several other research firms have also recently issued reports on CELH. Rothschild & Co Redburn initiated coverage on Celsius […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Piper Sandler Cuts Restaurant Brands International (NYSE:QSR) Price Target to $81.00 | 0 | 12.25 | 10-08-2026 |
| 2 | Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler | 0 | 9.05 | 10-08-2026 |
| 3 | Piper Sandler Cuts Molson Coors Beverage (NYSE:TAP) Price Target to $44.00 | 0 | 9.52 | 10-08-2026 |
| 4 | Collegium Pharmaceutical’s (COLL) “Neutral” Rating Reiterated at Piper Sandler | 0 | 9.68 | 10-08-2026 |
| 5 | Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $20.00 | 0 | 11.9 | 10-08-2026 |
| 6 | Piper Sandler Cuts Papa John’s International (NASDAQ:PZZA) Price Target to $26.00 | 0 | 11.89 | 10-08-2026 |
| 7 | Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00 | 0 | 10.45 | 10-08-2026 |
| 8 | Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $53.00 | 0 | 11.84 | 10-08-2026 |
| 9 | Somnigroup International’s (SGI) “Overweight” Rating Reiterated at Piper Sandler | 0 | 9.05 | 10-08-2026 |
| 10 | Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler | 0 | 8.45 | 10-08-2026 |